Trust Investment Advisors Sells 3,052 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Trust Investment Advisors trimmed its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 9.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 30,291 shares of the pharmacy operator’s stock after selling 3,052 shares during the quarter. Trust Investment Advisors’ holdings in Walgreens Boots Alliance were worth $791,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Vanguard Group Inc. raised its position in Walgreens Boots Alliance by 14.5% during the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after purchasing an additional 10,962,030 shares in the last quarter. Moneta Group Investment Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 84,503.5% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 8,325,830 shares of the pharmacy operator’s stock worth $311,053,000 after buying an additional 8,315,989 shares in the last quarter. Invesco Ltd. grew its position in Walgreens Boots Alliance by 21.5% in the third quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock valued at $378,668,000 after acquiring an additional 3,013,807 shares during the last quarter. BlackRock Inc. grew its holdings in shares of Walgreens Boots Alliance by 4.6% during the 1st quarter. BlackRock Inc. now owns 63,406,129 shares of the pharmacy operator’s stock valued at $2,192,584,000 after purchasing an additional 2,797,885 shares during the last quarter. Finally, Morgan Stanley grew its stake in shares of Walgreens Boots Alliance by 15.8% during the third quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock worth $279,876,000 after buying an additional 1,720,228 shares during the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Valerie B. Jarrett purchased 4,456 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were bought at an average price of $22.44 per share, with a total value of $99,992.64. Following the acquisition, the director now owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan bought 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the transaction, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock in a transaction dated Monday, January 29th. The stock was acquired at an average price of $22.44 per share, with a total value of $99,992.64. Following the purchase, the director now directly owns 4,456 shares of the company’s stock, valued at $99,992.64. The disclosure for this purchase can be found here. Insiders purchased 13,456 shares of company stock valued at $270,423 in the last three months. Company insiders own 17.40% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on WBA shares. Morgan Stanley decreased their price target on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research report on Monday, April 1st. TheStreet raised Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research note on Monday, January 8th. TD Cowen reduced their price target on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a report on Wednesday, April 3rd. Barclays began coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a research report on Wednesday, April 3rd. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $24.36.

Walgreens Boots Alliance Stock Down 0.2 %

Walgreens Boots Alliance stock traded down $0.04 during midday trading on Thursday, hitting $17.59. 6,713,018 shares of the stock were exchanged, compared to its average volume of 14,249,123. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $15.18 billion, a price-to-earnings ratio of -2.52, a price-to-earnings-growth ratio of 1.09 and a beta of 0.73. Walgreens Boots Alliance, Inc. has a 52-week low of $17.51 and a 52-week high of $36.14. The business’s 50-day moving average price is $20.60 and its 200-day moving average price is $21.98.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. Walgreens Boots Alliance’s revenue was up 6.3% on a year-over-year basis. During the same period last year, the business posted $1.16 earnings per share. On average, research analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.